[go: up one dir, main page]

Listgarten et al., 2005 - Google Patents

Practical proteomic biomarker discovery: taking a step back to leap forward

Listgarten et al., 2005

View PDF
Document ID
656533989934510790
Author
Listgarten J
Emili A
Publication year
Publication venue
Drug discovery today

External Links

Snippet

There is a pressing need for radically improved proteomic screening methods that allow for earlier diagnosis of disease, for systematic monitoring of physiological responses and for uncovering the fundamental mechanisms of drug action. Recent developments in proteomic …
Continue reading at www.jennifer.listgarten.com (PDF) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06F—ELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
    • G06F19/34—Computer-assisted medical diagnosis or treatment, e.g. computerised prescription or delivery of medication or diets, computerised local control of medical devices, medical expert systems or telemedicine
    • G06F19/345—Medical expert systems, neural networks or other automated diagnosis
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06F—ELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/10—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology
    • G06F19/28—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology for programming tools or database systems, e.g. ontologies, heterogeneous data integration, data warehousing or computing architectures
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using infra-red, visible or ultra-violet light
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06F—ELECTRICAL DIGITAL DATA PROCESSING
    • G06F17/00—Digital computing or data processing equipment or methods, specially adapted for specific functions

Similar Documents

Publication Publication Date Title
Nakayasu et al. Tutorial: best practices and considerations for mass-spectrometry-based protein biomarker discovery and validation
Zhang et al. Evaluation of a novel, integrated approach using functionalized magnetic beads, bench-top MALDI-TOF-MS with prestructured sample supports, and pattern recognition software for profiling potential biomarkers in human plasma
Kenny et al. Novel biomarkers for pre-eclampsia detected using metabolomics and machine learning: LC Kenny et al.
EP2232269B1 (en) Methods and biomarkers for diagnosing and monitoring psychotic disorders
Giovanella et al. Thyroglobulin measurement by highly sensitive assays: focus on laboratory challenges
JP2025041616A (en) Automated Boundary Detection in Mass Spectrometry Data
Fusaro et al. Prediction of high-responding peptides for targeted protein assays by mass spectrometry
JP7250693B2 (en) Plasma-based protein profiling for early-stage lung cancer diagnosis
Ketterlinus et al. Fishing for biomarkers: analyzing mass spectrometry data with the new ClinProTools™ software
Chau et al. Critical considerations in N-glycoproteomics
Surinova et al. Automated selected reaction monitoring data analysis workflow for large-scale targeted proteomic studies
US7949475B2 (en) System and method for analyzing metabolomic data
White et al. Bioinformatics strategies for proteomic profiling
Moore et al. Prospective on imaging mass spectrometry in clinical diagnostics
Rischke et al. Small molecule biomarker discovery: Proposed workflow for LC-MS-based clinical research projects
Daly et al. Evaluating concentration estimation errors in ELISA microarray experiments
Listgarten et al. Practical proteomic biomarker discovery: taking a step back to leap forward
US7433787B2 (en) System, method, and computer program product using a database in a computing system to compile and compare metabolomic data obtained from a plurality of samples
CN113917152B (en) Application of urine protein marker in preparation of kit for detecting diabetic nephropathy
Baumgartner et al. A novel network-based approach for discovering dynamic metabolic biomarkers in cardiovascular disease
Singh et al. Protein Biomarkers: Discovery and Applications in Clinical Diagnostics
US20240321448A1 (en) Artificial intelligence for identifying one or more predictive biomarkers
Schwarz et al. Clinical bioinformatics for complex disorders: a schizophrenia case study
Timucin et al. Antibody array–based immunosensor for detecting cardiovascular disease risk markers
WO2011119967A2 (en) System,method and computer-accessible medium for evaluating a maliganacy status in at-risk populations and during patient treatment management